TGFB1 and pemphigus foliaceus: The special structure of the lung poses a challenge for the treatment of PF, and although BBR can protect the lung structure and reduce lung damage through various pathways (such as TGF-β) (Figure 4), researchers are encouraged to conduct in-depth studies, especially clinical studies, to provide stronger and more comprehensive evidence for the treatment of fibrotic diseases with BBR.